Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents

Bioorganic & Medicinal Chemistry(2020)10.1016/j.bmc.2020.115952Source: DataRank Database

Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents is a research paper published in Bioorganic & Medicinal Chemistry (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.23)OA: greenTopics (42)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Sébastien Bouclé ORCID,Leda Bassit ORCID,Zhe Chen ORCID,Ozkan Sari,Bryan D. Cox ORCID

Live enrichment

PubMed:33421915 OpenAlex:https://openalex.org/W3111081967

National Institutes of Health

Grant: 1-R01-AI-132833

National Institutes of Health

Grant: 5P30AI050409-20

Center for AIDS Research at Emory University

National Institutes of Health

Grant: 1R01AI132833-01

HBV Capsid Effectors

NIAID NIH HHS

Grant: P30 AI050409

NIAID NIH HHS

Grant: R01 AI132833

NIAID NIH HHS

Grant: R56 AI132833

FWCI

1.23

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7856252

publisherhttps://api.elsevier.com/content/article/PII:S0968089620307823?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0968089620307823?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bmc.2020.115952

Fields of Study

Hepatitis B Virus StudiesHepatitis C virus researchLiver Disease Diagnosis and Treatment0301 basic medicine03 medical and health sciences0302 clinical medicineAntiviral AgentsDose-Response Relationship, DrugDrug DiscoveryHepatitis B virusMicrobial Sensitivity TestsMolecular StructureStructure-Activity RelationshipSulfonylurea Compounds

MeSH Terms

Antiviral AgentsDose-Response Relationship, DrugHepatitis B virusMicrobial Sensitivity TestsStructure-Activity RelationshipSulfonylurea CompoundsMolecular StructureDrug Discovery

Keywords

cccDNAHepatitis B virusVirologyHBeAgVirusChemistryHepatitis BSecretionBiologyHBsAgBiochemistryStructure-Activity RelationshipSulfonylurea CompoundsDose-Response Relationship, DrugMolecular StructureDrug DiscoveryMicrobial Sensitivity TestsAntiviral AgentsAntiviralCapsid

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being